These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 32446320)

  • 1. Opposing Functions of BRD4 Isoforms in Breast Cancer.
    Wu SY; Lee CF; Lai HT; Yu CT; Lee JE; Zuo H; Tsai SY; Tsai MJ; Ge K; Wan Y; Chiang CM
    Mol Cell; 2020 Jun; 78(6):1114-1132.e10. PubMed ID: 32446320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromodomain Protein BRD4-Mediated Mutant p53 Transcription Promotes TNBC Progression.
    Zhou JX; Agborbesong E; Li LX; Li X
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499487
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.
    Shu S; Wu HJ; Ge JY; Zeid R; Harris IS; Jovanović B; Murphy K; Wang B; Qiu X; Endress JE; Reyes J; Lim K; Font-Tello A; Syamala S; Xiao T; Reddy Chilamakuri CS; Papachristou EK; D'Santos C; Anand J; Hinohara K; Li W; McDonald TO; Luoma A; Modiste RJ; Nguyen QD; Michel B; Cejas P; Kadoch C; Jaffe JD; Wucherpfennig KW; Qi J; Liu XS; Long H; Brown M; Carroll JS; Brugge JS; Bradner J; Michor F; Polyak K
    Mol Cell; 2020 Jun; 78(6):1096-1113.e8. PubMed ID: 32416067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple-negative breast cancer.
    Pascual-Reguant L; Serra-Camprubí Q; Datta D; Cianferoni D; Kourtis S; Gañez-Zapater A; Cannatá C; Espinar L; Querol J; García-López L; Musa-Afaneh S; Guirola M; Gkanogiannis A; Miró Canturri A; Guzman M; Rodríguez O; Herencia-Ropero A; Arribas J; Serra V; Serrano L; Tian TV; Peiró S; Sdelci S
    EMBO Mol Med; 2023 Dec; 15(12):e18459. PubMed ID: 37937685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRD4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma.
    Das D; Leung JY; Balamurugan S; Tergaonkar V; Loh AHP; Chiang CM; Taneja R
    EMBO Rep; 2024 Feb; 25(2):832-852. PubMed ID: 38191874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromodomain 4 activation predicts breast cancer survival.
    Crawford NP; Alsarraj J; Lukes L; Walker RC; Officewala JS; Yang HH; Lee MP; Ozato K; Hunter KW
    Proc Natl Acad Sci U S A; 2008 Apr; 105(17):6380-5. PubMed ID: 18427120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H4K12ac is regulated by estrogen receptor-alpha and is associated with BRD4 function and inducible transcription.
    Nagarajan S; Benito E; Fischer A; Johnsen SA
    Oncotarget; 2015 Mar; 6(9):7305-17. PubMed ID: 25788266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRD4 inhibition suppresses PD-L1 expression in triple-negative breast cancer.
    Jing X; Shao S; Zhang Y; Luo A; Zhao L; Zhang L; Gu S; Zhao X
    Exp Cell Res; 2020 Jul; 392(2):112034. PubMed ID: 32339606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatially constrained tandem bromodomain inhibition bolsters sustained repression of BRD4 transcriptional activity for TNBC cell growth.
    Ren C; Zhang G; Han F; Fu S; Cao Y; Zhang F; Zhang Q; Meslamani J; Xu Y; Ji D; Cao L; Zhou Q; Cheung KL; Sharma R; Babault N; Yi Z; Zhang W; Walsh MJ; Zeng L; Zhou MM
    Proc Natl Acad Sci U S A; 2018 Jul; 115(31):7949-7954. PubMed ID: 30012592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of BRD4 suppresses the malignancy of breast cancer cells via regulation of Snail.
    Lu L; Chen Z; Lin X; Tian L; Su Q; An P; Li W; Wu Y; Du J; Shan H; Chiang CM; Wang H
    Cell Death Differ; 2020 Jan; 27(1):255-268. PubMed ID: 31114028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer.
    Nerlakanti N; Yao J; Nguyen DT; Patel AK; Eroshkin AM; Lawrence HR; Ayaz M; Kuenzi BM; Agarwal N; Chen Y; Gunawan S; Karim RM; Berndt N; Puskas J; Magliocco AM; Coppola D; Dhillon J; Zhang J; Shymalagovindarajan S; Rix U; Kim Y; Perera R; Lawrence NJ; Schonbrunn E; Mahajan K
    Mol Cancer Ther; 2018 Dec; 17(12):2796-2810. PubMed ID: 30242092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRD4 bimodal binding at promoters and drug-induced displacement at Pol II pause sites associates with I-BET sensitivity.
    Khoueiry P; Ward Gahlawat A; Petretich M; Michon AM; Simola D; Lam E; Furlong EE; Benes V; Dawson MA; Prinjha RK; Drewes G; Grandi P
    Epigenetics Chromatin; 2019 Jul; 12(1):39. PubMed ID: 31266503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p113 isoform encoded by CUX1 circular RNA drives tumor progression via facilitating ZRF1/BRD4 transactivation.
    Yang F; Hu A; Guo Y; Wang J; Li D; Wang X; Jin S; Yuan B; Cai S; Zhou Y; Li Q; Chen G; Gao H; Zheng L; Tong Q
    Mol Cancer; 2021 Sep; 20(1):123. PubMed ID: 34579723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer.
    Kim YJ; Sung M; Oh E; Vrancken MV; Song JY; Jung K; Choi YL
    Cancer Biol Ther; 2018 Apr; 19(4):335-345. PubMed ID: 29333926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brd4-bound enhancers drive cell-intrinsic sex differences in glioblastoma.
    Kfoury N; Qi Z; Prager BC; Wilkinson MN; Broestl L; Berrett KC; Moudgil A; Sankararaman S; Chen X; Gertz J; Rich JN; Mitra RD; Rubin JB
    Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33850013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.
    Shi J; Wang Y; Zeng L; Wu Y; Deng J; Zhang Q; Lin Y; Li J; Kang T; Tao M; Rusinova E; Zhang G; Wang C; Zhu H; Yao J; Zeng YX; Evers BM; Zhou MM; Zhou BP
    Cancer Cell; 2014 Feb; 25(2):210-25. PubMed ID: 24525235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition.
    Andrieu GP; Denis GV
    Mol Cancer Res; 2018 Apr; 16(4):580-586. PubMed ID: 29437854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRD4-directed super-enhancer organization of transcription repression programs links to chemotherapeutic efficacy in breast cancer.
    Liu B; Liu X; Han L; Chen X; Wu X; Wu J; Yan D; Wang Y; Liu S; Shan L; Zhang Y; Shang Y
    Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35105803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA MANCR is a target of BET bromodomain protein BRD4 and plays a critical role in cellular migration and invasion abilities of prostate cancer.
    Nagasawa M; Tomimatsu K; Terada K; Kondo K; Miyazaki K; Miyazaki M; Motooka D; Okuzaki D; Yoshida T; Kageyama S; Kawamoto H; Kawauchi A; Agata Y
    Biochem Biophys Res Commun; 2020 May; 526(1):128-134. PubMed ID: 32199616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRD4L cooperates with MYC to block local tumor invasion via suppression of S100A10.
    Ma Y; Liu N; Shi Y; Ma S; Wang Y; Zheng W; Sun R; Song Y; Chen M; Qu L; Mao R; Fan Y
    Cell Signal; 2024 Jul; 119():111173. PubMed ID: 38604343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.